1. Home
  2. EDBL vs MYNZ Comparison

EDBL vs MYNZ Comparison

Compare EDBL & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDBL
  • MYNZ
  • Stock Information
  • Founded
  • EDBL 2020
  • MYNZ 2021
  • Country
  • EDBL United States
  • MYNZ Germany
  • Employees
  • EDBL N/A
  • MYNZ N/A
  • Industry
  • EDBL Farming/Seeds/Milling
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDBL Consumer Staples
  • MYNZ Health Care
  • Exchange
  • EDBL Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • EDBL 7.2M
  • MYNZ 7.6M
  • IPO Year
  • EDBL 2022
  • MYNZ 2021
  • Fundamental
  • Price
  • EDBL $2.61
  • MYNZ $2.04
  • Analyst Decision
  • EDBL
  • MYNZ Buy
  • Analyst Count
  • EDBL 0
  • MYNZ 2
  • Target Price
  • EDBL N/A
  • MYNZ $14.00
  • AVG Volume (30 Days)
  • EDBL 127.1K
  • MYNZ 185.7K
  • Earning Date
  • EDBL 08-13-2025
  • MYNZ 08-05-2025
  • Dividend Yield
  • EDBL N/A
  • MYNZ N/A
  • EPS Growth
  • EDBL N/A
  • MYNZ N/A
  • EPS
  • EDBL N/A
  • MYNZ N/A
  • Revenue
  • EDBL $13,443,000.00
  • MYNZ $893,991.00
  • Revenue This Year
  • EDBL $29.56
  • MYNZ $26.06
  • Revenue Next Year
  • EDBL $20.00
  • MYNZ $4.97
  • P/E Ratio
  • EDBL N/A
  • MYNZ N/A
  • Revenue Growth
  • EDBL N/A
  • MYNZ N/A
  • 52 Week Low
  • EDBL $1.80
  • MYNZ $1.34
  • 52 Week High
  • EDBL $39.50
  • MYNZ $19.00
  • Technical
  • Relative Strength Index (RSI)
  • EDBL 45.87
  • MYNZ 57.11
  • Support Level
  • EDBL $2.54
  • MYNZ $1.89
  • Resistance Level
  • EDBL $2.76
  • MYNZ $2.25
  • Average True Range (ATR)
  • EDBL 0.13
  • MYNZ 0.22
  • MACD
  • EDBL 0.01
  • MYNZ 0.05
  • Stochastic Oscillator
  • EDBL 54.05
  • MYNZ 76.14

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: